TGFB1 and pulmonary arterial hypertension: Haploinsufficient loss-of-function mutations in the bone morphogenetic protein type 2 receptor (BMPR2) gene, a member of the transforming growth factor-beta (TGF-β) superfamily, account for over 80% of hereditary PAH cases and approximately 20% of idiopathic PAH cases [4].